University of Arizona researchers investigate long COVID sleep issues

University of Arizona researchers investigate long COVID sleep issues

Researchers at the University of Arizona are working to understand and treat sleep problems linked to long COVID, a condition affecting nearly 7% of Arizonans.Dr. Sairam Parthasarathy, the director of the Center for Sleep and Circadian Sciences at U of A Health Sciences, is part of a study investigating sleep disorders such as insomnia, sleep apnea, and extreme fatigue, which may persist after a COVID infection."Problems can be pretty severe and…

Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome: Real-World Evidence

Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome: Real-World Evidence Post-COVID syndrome (PCS), or long COVID, is a multisystemic complication that usually occurs 3 months after a SARS-CoV-2 infection, persists for at least 2 months, and cannot be explained by an alternative diagnosis.1 The incidence of PCS ranges from 10% to 70%, depending on the definition, with most estimates at approximately 20%.…

Clinical Trial Underway For Potential Long Covid Treatment - Healthcare Business Today

Image Source: Dr. Nancy Klimas / Photo Credit: Cory Galiszewski A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today. ... Read more The post Clinical trial underway for potential …

Clinical trial underway for potential Long COVID treatment - Caribbean News Global

Nova Southeastern University and the Schmidt Initiative for Long COVID will study the efficacy of a long-acting antibody for treating Long COVID – Schmidt Institute for Long Covid FORT LAUDERDALE, USA — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern Unive…

US scientists to explore potential of antibody against Long Covid - tennews.in: National News Portal

New Delhi, May 3 (IANS) US scientists are undertaking a clinical trial to decode the efficacy of a long-acting antibody against Long Covid — a condition that affects at least 65 million people worldwide. Long Covid affects people after an infection caused by the SARS-CoV-2 virus. The condition not properly defined yet presents with more […] The post US scientists to explore potential of antibody against Long Covid appeared first on tennews.in: N…